Top compounds associated with response to DEFB107A


Feature Type Standardized
Nominal ANOVA
mRNA istradefylline CTRPv2 pan-cancer AAC 0.038 0.5
mRNA myricetin CTRPv2 pan-cancer AAC -0.025 0.5
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.024 0.5
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.023 0.5
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.5
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.028 0.5
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.5
mRNA SKI-II CTRPv2 pan-cancer AAC -0.024 0.5
Download CSV